Two endowed chairs focus on cancer, brain research
Contact: Peggy Binette or Megan Sexton 803-777-5400 firstname.lastname@example.org email@example.com
Two new SmartState endowed chairs at the University of South Carolina will conduct research on cancer therapeutics and brain activity in stroke patients.
Dr. Chris Rorden has joined USC as the SmartState Chair in Neuroimaging Research. Rordan is also a professor of psychology and director of the McCausland Center for Brain Imaging.
Dr. Chris Rorden
Rorden studies the behavioral difficulties experienced by individuals after brain injury. Most of his work centers on stroke, the leading cause of disability in the United States. He uses neuroimages to study brain activity and brain stimulation, to understand the speech and perception difficulties that result from stroke and to predict treatments. He also studies epilepsy, the leading major neurological disorder.
“The college is delighted that Professor Rordan is serving as the scientific leader of the McCausland Center for Brain Imaging, which uses emerging methods to understand brain function in infants, children and adults,” said Dr. Mary Anne Fitzpatrick, dean of the College of Arts and Sciences.
Dr. Igor Roninson, whose research focuses on cancer therapeutics, has joined the South Carolina College of Pharmacy as the SmartState Chair in Translational Cancer Therapeutics. He brought with him international prestige, a biotechnology company, several fellow scientists and new hope through discovery of novel drugs.
Dr. Igor Roninson
“Igor Roninson is a very well recognized scientist in cancer therapeutics, and we are very fortunate to have him and his group come to South Carolina ,” said Dr. Joseph DiPiro, dean of the South Carolina College of Pharmacy. “He has brought an active academic research program as well as his company, Senex Biotechnology, and he will help us bring our cancer research to a much higher level.”